ACTINIC KERATOSIS (AK)
Clinical trials for ACTINIC KERATOSIS (AK) explained in plain language.
Never miss a new study
Get alerted when new ACTINIC KERATOSIS (AK) trials appear
Sign up with your email to follow new studies for ACTINIC KERATOSIS (AK), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New sunscreen aims to stop skin spots before they turn dangerous
Prevention Recruiting nowThis study tests whether a new sunscreen, Anthelios Fluide 100 KA+ UVMune 400, can prevent actinic keratosis (AK) — rough, scaly spots that can turn into skin cancer — in people aged 60 and older who already have many of these spots. Participants will be randomly assigned to use …
Matched conditions: ACTINIC KERATOSIS (AK)
Phase: NA • Sponsor: Cosmetique Active International • Aim: Prevention
Last updated May 14, 2026 12:05 UTC
-
New ointment for Sun-Damaged skin spots enters early human testing
Symptom relief Recruiting nowThis early-stage study tests a new ointment called HW211026 for actinic keratosis, rough patches on skin caused by sun damage. The main goal is to check if the ointment is safe and how the body handles it. About 40 adults with mild to moderate actinic keratosis on the face will a…
Matched conditions: ACTINIC KERATOSIS (AK)
Phase: PHASE1 • Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:03 UTC
-
New cream could zap precancerous skin spots without surgery
Symptom relief Recruiting nowThis early-stage study tests a new cream called RLS-1496 for actinic keratosis, a rough, scaly skin patch that can turn into skin cancer. About 24 adults will apply the cream to one forearm daily for 28 days, leaving the other arm untreated for comparison. Researchers will check …
Matched conditions: ACTINIC KERATOSIS (AK)
Phase: PHASE1, PHASE2 • Sponsor: Rubedo Life Sciences, Inc. • Aim: Symptom relief
Last updated May 07, 2026 18:39 UTC